Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-22

Clinical Trial Update: Can Drospirenone be Used to Prevent LH Surge in Controlled Ovarian Stimulation in PCOS?! [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated whether drospirenone can prevent the LH surge during controlled ovarian stimulation in women with polycystic ovary syndrome…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Drospirenone (Drospirenone)

Snippet

Sponsor: Ahmed Saad | Conditions: PCOS (Polycystic Ovary Syndrome) | Phase 1, Phase 2 | Status: COMPLETED